Radiation damage to the heart enhances early radiation-induced lung function loss

Cancer Research

Volumn 65, Issue 15, 2005, Pages 6509-6511

  Van Luijk, Peter ^a   Novakova Jiresova, Alena ^a   Faber, Hette ^a   Schippers, Jacobus M ^b   Kampinga, Harm H ^a   Meertens, Harm ^a   Coppes, Rob P ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b PAUL SCHERRER INSTITUTE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREATHING RATE; CONTROLLED STUDY; HEART INJURY; LUNG INJURY; LUNG PARENCHYMA; LUNG TOXICITY; MORBIDITY; NONHUMAN; PRIORITY JOURNAL; PROTON RADIATION; RADIATION DOSE DISTRIBUTION; RADIATION INJURY; RAT; RISK FACTOR; THORAX CANCER;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, RADIATION; HEART; HEART DISEASES; LUNG; RADIATION INJURIES, EXPERIMENTAL; RADIATION TOLERANCE; RATS; RATS, WISTAR;

EID: 23044468877     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-05-0786     Document Type: Article

References (20)

1. Lee CH, Tait D, Nahum AE, Webb S. Comparison of proton therapy and conformal X-ray therapy in non-small cell lung cancer (NSCLC). Br J Radiol 1999;72: 1078-84.
2. Engelsman M, Remeijer P, van Herk M, Lebesque JV, Mijnheer BJ, Damen EM. Field size reduction enables iso-NTCP escalation of tumor control probability for irradiation of lung tumors. Int J Radiat Oncol Biol Phys 2001;51:1290-8.
3. Ishikura S, Nihei K, Ohtsu A, et al. Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus. J Clin Oncol 2003; 21:2697-702.
4. Koyama S, Tsujii H. Proton beam therapy with high-dose irradiation for superficial and advanced esophageal carcinomas. Clin Cancer Res 2003;9:3571-7.
5. Kamada T, Tsujii H, Tsuji H, et al. Efficacy and safety of carbon ion radiotherapy in bone and soft tissue sarcomas. J Clin Oncol 2002;20:4466-71.
6. Novakova-Jiresova A, van Luijk P, van Goor H, Kampinga HH, Coppes RP. Pulmonary radiation injury: identification of risk factors associated with regional hypersensitivity. Cancer Res 2005;65:3568-76.
7. Travis EL, Liao ZX, Tucker SL. Spatial heterogeneity of the volume effect for radiation pneumonitis in mouse lung. Int J Radiat Oncol Biol Phys 1997;38:1045-54.
8. Gyenes G, Rutqvist LE, Liedberg A, Fornander T. Long-term cardiac morbidity and mortality in a randomized trial of pre- and postoperative radiation therapy versus surgery alone in primary breast cancer. Radiother Oncol 1998;48:185-90.
9. Gagliardi G, Lax I, Soderstrom S, Gyenes G, Rutqvist LE. Prediction of excess risk of long-term cardiac mortality after radiotherapy of stage I breast cancer. Radiother Oncol 1998;46:63-71.
10. van Luijk P, Bijl HP, Coppes RP, et al. Techniques for precision irradiation of the lateral half of the rat cervical spinal cord using 150 MeV protons. Phys Med Biol 2001; 46:2857-71.
11. van Luijk P, Delvigne TC, Schilstra C, Schippers JM. Estimation of parameters of dose-volume models and their confidence limits. Phys Med Biol 2003;48: 1863-84.
12. Geist BJ, Lauk S, Bornhausen M, Trott KR. Physiologic consequences of local heart irradiation in rats. Int J Radiat Oncol Biol Phys 1990;18:1107-13.
13. McDonald S, Rubin P, Phillips TL, Marks LB. Injury to the lung from cancer therapy: clinical syndromes, measurable endpoints, and potential scoring systems. Int J Radiat Oncol Biol Phys 1995;31:1187-203.
14. McChesney SL, Gillette EL, Orton EC. Canine cardiomyopathy after whole heart and partial lung irradiation. Int J Radiat Oncol Biol Phys 1988;14:1169-74.
15. Travis EL, Down JD, Holmes SJ, Hobson B. Radiation pneumonitis and fibrosis in mouse lung assayed by respiratory frequency and histology. Radiat Res 1980;84: 133-43.
16. Schultz-Hector S. Radiation-induced heart disease: review of experimental data on dose response and pathogenesis. Int J Radiat Biol 1992;61:149-60.
17. Ikaheimo MJ, Niemela KO, Linnaluoto MM, Jakobsson MJ, Takkunen JT, Taskinen PJ. Early cardiac changes related to radiation therapy. Am J Cardiol 1985;56:943-6.
18. Lagrange JL, Darcourt J, Benoliel J, Bensadoun RJ, Migneco O. Acute cardiac effects of mediastinal irradiation: assessment by radionuclide angiography. Int J Radiat Oncol Biol Phys 1992;22:897-903.
19. Narayan S, Henning GT, Ten Haken RK, Sullivan MA, Martel MK, Hayman JA. Results following treatment to doses of 92.4 or 102.9 Gy on a phase I dose escalation study for non-small cell lung cancer. Lung Cancer 2004; 44:79-88.
20. Hayman JA, Martel MK, Ten Haken RK, et al. Dose escalation in non-small-cell lung cancer using three-dimensional conformal radiation therapy: update of a phase I trial. J Clin Oncol 2001;19:127-36.